Teva Pharmaceuticals Acquires Emalex Biosciences
Teva Pharmaceuticals acquired Emalex Biosciences for $700.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- Teva Pharmaceuticals
- Acquired Company
- Emalex Biosciences
- Price
- $700.0M
- Acquisition Type
- Acquisition
- Announced
- April 29, 2026
Canonical: https://fsome.com/acquisitions/teva-pharmaceuticals-acquires-emalex-biosciences-17270131 · For the full deal terms, timeline, and press references, please enable JavaScript.